The current screening for trisomy 21, 18 by applying markers such as maternal serum free human chorionic gonadotropin (free β-hCG) and alpha-fetoprotein (AFP) in second trimester has evolved into a routine obstetric examination4. Here, AFP is linked to trisomy 21.